Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
0 hedge funds and large institutions have $0 invested in Onconova Therapeutics, Inc. Warrants in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $7K → $0 (-$7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2K |
ONTXW Hedge Fund Activity: Q3 2021 in Review
0 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q3 2021, worth a combined $0 — down 100% from $7K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ONTXW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Virtu Financial, exiting entirely with an estimated $5K sold.
- 0 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q3 2021, down from 2 in Q2 2021.
- Funds reported $0 of Onconova Therapeutics, Inc. Warrants stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q3 2021 and 2 closed out, a net change of -2 holders.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q3 2021 was Virtu Financial, an estimated $5K sold.
Based on aggregated 13F filings for Q3 2021.